Join over 800 global experts to explore breakthroughs in cancer immunotherapy, biomarker-driven drug development, and AI-enabled companion diagnostics innovation. Connect with leaders in pharmaceuticals, diagnostics, and clinical practice to shape the future of precision medicine.